A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
Clinical trial NCT06223308 · UNKNOWN
Trial details
- NCT number
- NCT06223308
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-09
- Primary completion
- 2024-05-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.